Prognostic associations have been reported for some inflammatory biomarkers (e.g., interleukin-6 (IL-6) and C-reactive protein (CRP)) in the prediction of functional outcome after stroke,58,59 which could be either related to the inflammation itself, but also the degree of tissue injury or intercurrent infection which may each contribute to the inflammatory response. This evidence concerns the gene CRP and stroke disorder.